N-Acetilglükózamin (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "N-Acetilglükózamin" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

11nih.gov

4^th place

11^th place

5doi.org

2^nd place

8^th place

1archive.org

6^th place

14^th place

archive.org

Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011). „Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease”. Annual Review of Biochemistry 80, 825–858. o. DOI:10.1146/annurev-biochem-060608-102511. PMID 21391816. PMC 3294376.

doi.org

dx.doi.org

Grigorian A, Araujo L, Naidu NN, Place DJ, Choudhury B, Demetriou M (2011. november 1.). „N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis”. The Journal of Biological Chemistry 286 (46), 40133–40141. o. DOI:10.1074/jbc.M111.277814. PMID 21965673. PMC 3220534.
Sy M, Newton BL, Pawling J, Hayama KL, Cordon A, Yu Z, Kuhle J, Dennis JW, Brandt AU, Demetriou M (2023. szeptember 1.). „N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial”. Journal of Neuroinflammation 20 (1), 209. o. DOI:10.1186/s12974-023-02893-9. PMID 37705084. PMC 10498575.
Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011). „Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease”. Annual Review of Biochemistry 80, 825–858. o. DOI:10.1146/annurev-biochem-060608-102511. PMID 21391816. PMC 3294376.
Ma J, Hart G (2013. augusztus 1.). „Protein O-GlcNAcylation in diabetes and diabetic complications”. Expert Review of Proteomics 10 (4), 365–380. o. DOI:10.1586/14789450.2013.820536. PMID 23992419. PMC 3985334.
Wheatley EG, Albarran E, White CW, Bieri G, Sanchez-Diaz C, Pratt K, Snethlage CE, Ding JB, Villeda SA (2019. október 1.). „Neuronal O-GlcNAcylation Improves Cognitive Function in the Aged Mouse Brain”. Current Biology 29 (20), 3359–3369.e4. o. DOI:10.1016/j.cub.2019.08.003. PMID 31588002. PMC 7199460.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kamel M, Hanafi M, Bassiouni M (1991). „Inhibition of elastase enzyme release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamine”. Clinical and Experimental Rheumatology 9 (1), 17–21. o. PMID 2054963.
Grigorian A, Araujo L, Naidu NN, Place DJ, Choudhury B, Demetriou M (2011. november 1.). „N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis”. The Journal of Biological Chemistry 286 (46), 40133–40141. o. DOI:10.1074/jbc.M111.277814. PMID 21965673. PMC 3220534.
Sy M, Newton BL, Pawling J, Hayama KL, Cordon A, Yu Z, Kuhle J, Dennis JW, Brandt AU, Demetriou M (2023. szeptember 1.). „N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial”. Journal of Neuroinflammation 20 (1), 209. o. DOI:10.1186/s12974-023-02893-9. PMID 37705084. PMC 10498575.
Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011). „Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease”. Annual Review of Biochemistry 80, 825–858. o. DOI:10.1146/annurev-biochem-060608-102511. PMID 21391816. PMC 3294376.
Ma J, Hart G (2013. augusztus 1.). „Protein O-GlcNAcylation in diabetes and diabetic complications”. Expert Review of Proteomics 10 (4), 365–380. o. DOI:10.1586/14789450.2013.820536. PMID 23992419. PMC 3985334.
Wheatley EG, Albarran E, White CW, Bieri G, Sanchez-Diaz C, Pratt K, Snethlage CE, Ding JB, Villeda SA (2019. október 1.). „Neuronal O-GlcNAcylation Improves Cognitive Function in the Aged Mouse Brain”. Current Biology 29 (20), 3359–3369.e4. o. DOI:10.1016/j.cub.2019.08.003. PMID 31588002. PMC 7199460.

ncbi.nlm.nih.gov

Grigorian A, Araujo L, Naidu NN, Place DJ, Choudhury B, Demetriou M (2011. november 1.). „N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis”. The Journal of Biological Chemistry 286 (46), 40133–40141. o. DOI:10.1074/jbc.M111.277814. PMID 21965673. PMC 3220534.
Sy M, Newton BL, Pawling J, Hayama KL, Cordon A, Yu Z, Kuhle J, Dennis JW, Brandt AU, Demetriou M (2023. szeptember 1.). „N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial”. Journal of Neuroinflammation 20 (1), 209. o. DOI:10.1186/s12974-023-02893-9. PMID 37705084. PMC 10498575.
Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011). „Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease”. Annual Review of Biochemistry 80, 825–858. o. DOI:10.1146/annurev-biochem-060608-102511. PMID 21391816. PMC 3294376.
Ma J, Hart G (2013. augusztus 1.). „Protein O-GlcNAcylation in diabetes and diabetic complications”. Expert Review of Proteomics 10 (4), 365–380. o. DOI:10.1586/14789450.2013.820536. PMID 23992419. PMC 3985334.
Wheatley EG, Albarran E, White CW, Bieri G, Sanchez-Diaz C, Pratt K, Snethlage CE, Ding JB, Villeda SA (2019. október 1.). „Neuronal O-GlcNAcylation Improves Cognitive Function in the Aged Mouse Brain”. Current Biology 29 (20), 3359–3369.e4. o. DOI:10.1016/j.cub.2019.08.003. PMID 31588002. PMC 7199460.